XML 60 R38.htm IDEA: XBRL DOCUMENT
v3.24.4

DERIVATIVE INSTRUMENTS (Tables) | 12 Months Ended
--- | ---
Nov. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The fair values of the Company’s derivative instruments are disclosed in Note 8—Fair Value Measurements and summarized in the table below:
|  | Value as of
Balance Sheet Line Item |  | November 30, 2024 |  | November 30, 2023
Derivative instruments not designated as hedging instruments: |  |  |  |
Foreign exchange forward contracts (notional value) |  | $ | 458,482 |  |  | $ | 2,173,330 |
Other current assets |  | 13,935 |  |  | 16,078 |
Other accrued liabilities |  | 167 |  |  | 20,856 |
Derivative instruments designated as fair value hedges: |  |  |  |
Cross-currency interest rate swaps (notional value) |  | $ | 471,604 |  |  | $ | 471,604 |
Other long-term liabilities |  | 7,468 |  |  | 17,219 |
Derivative instruments designated as cash flow hedges: |  |  |  |
Foreign exchange forward contracts (notional value) |  | $ | 1,049,787 |  |  | $ | 996,667 |
Other current assets and other assets |  | 578 |  |  | 14,330 |
Other accrued liabilities and other long-term liabilities |  | 22,155 |  |  | 2,724 |
Derivative Instruments, Gain (Loss) | The following table shows the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges and not designated as hedging instruments in other comprehensive income (“OCI”), and the consolidated statements of operations for the periods presented:
|  |  | Fiscal Years Ended November 30,
| Location of gain (loss) in statement of operations |  | 2024 |  | 2023 |  | 2022
Derivative instruments designated as cash flow and fair value hedges: |  |  |  |  |  |  |
(Losses) gains recognized in OCI: |  |  |  |  |  |  |
Foreign exchange forward contracts |  |  | $ | (38,459) |  |  | $ | 19,199 |  |  | $ | (60,891) |
Cross-currency interest rate swaps |  |  | (5,084) |  |  | (3,651) |  |  | — |
Total |  |  | $ | (43,543) |  |  | $ | 15,548 |  |  | $ | (60,891) |
(Losses) gains reclassified from AOCI into income: |  |  |  |  |  |  |
Foreign exchange forward contracts |  |  |  |  |  |  |
Gain reclassified from AOCI into income | Revenue for services |  | $ | — |  |  | $ | 222 |  |  | $ | — |
(Loss) gain reclassified from AOCI into income | Cost of revenue for services |  | (4,028) |  |  | (13,864) |  |  | (28,108) |
(Loss) gain reclassified from AOCI into income | Selling, general and administrative expenses |  | (861) |  |  | (4,745) |  |  | (8,121) |
Total |  |  | $ | (4,889) |  |  | $ | (18,387) |  |  | $ | (36,229) |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |
Gain (loss) recognized from foreign exchange forward contracts, net(1) | Other expense (income), net |  | $ | 9,940 |  |  | $ | (13,007) |  |  | $ | (57,983) |
Loss recognized from foreign exchange call options contracts, net | Other expense (income), net |  | — |  |  | (14,629) |  |  | — |
Total |  |  | $ | 9,940 |  |  | $ | (27,636) |  |  | $ | (57,983) |
(1) The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration